The Effect of Manual Lymphatic Drainage on Acute and Post-acute Ankle Sprain in Athletes
NCT ID: NCT06168240
Last Updated: 2024-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
80 participants
INTERVENTIONAL
2024-02-29
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Manual Lymph Drainage
NCT02360735
The Effect of Low-Intensity Blood Flow Restriction Therapy on the Management of Acute Ankle Sprains
NCT05596162
The Effect of Fascia Therapy and Transcutaneous Fibrolysis on Acute Ankle Sprain
NCT01249573
Physical Therapies in the Decongestive Treatment of Lymphedema
NCT01748604
The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries
NCT05844280
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Edema treatment includes a variety of techniques; elevation, compression, electrical stimulation, ultrasound, and massage are a few of them. Profound clinical check is required to determine the kind of edema management. However, the effect of these techniques on the lymphatic system and the edema itself is questionable. Manual Lymphatic Drainage mechanism, although still under investigation, is also a valid treatment management that does not cause inflammation, reduces the absorption of waste products and excess fluid and still urges the lymphatic system to work better.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
will receive Manual lymphatic drainage plus Traditional physical therapy program that will include LASER, cold packs, manual mobilization, and exercise program. Training will applied 3 days a week, for a total of 4 weeks.
Manual lymphatic drainage. will be applied three days per week for four weeks.
Training will applied 3 days a week, for a total of 4 weeks.
group B
will receive Traditional physical therapy program only that will include LASER, cold packs, manual mobilization, and exercise program. Training will applied 3 days a week, for a total of 4 weeks.
Manual lymphatic drainage. will be applied three days per week for four weeks.
Training will applied 3 days a week, for a total of 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manual lymphatic drainage. will be applied three days per week for four weeks.
Training will applied 3 days a week, for a total of 4 weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Serious pathology.
3. History of fractures in the ankle joint.
4. Vascular disorders.
5. Grade III ankle sprain.
18 Years
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sylvia Maher Mohsen Farid Hanna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sylvia Maher Mohsen Farid Hanna
master
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
012/003909
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.